Mesenchymal Stem Cell Therapy in Diabetic Kidney Disease-A Double-blind, Placebo-controlled, Randomized Clinical Trial

NCT07039318 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

78

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

BIOLOGICAL: Mesenchymal stem cells
DRUG: Normal Saline (Placebo)

Sponsor

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

Collaborators

[object Object]